Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Tableau, Mapbox, Exasol, and Alteryx commit $4.3 million to accelerate malaria elimination efforts for more than 60 million people


News provided by

Tableau

25 Apr, 2019, 07:00 GMT

Share this article

Share toX

Share this article

Share toX

Software and services donation will back expansion of PATH-led initiative in up to six countries across sub-Saharan Africa

PARIS, April 25, 2019 /PRNewswire/ -- Tableau (NYSE:DATA), Mapbox, Exasol, and Alteryx (NYSE: AYX) today announced a collective $4.3 million technology contribution over the next three years to help governments eliminate malaria for an estimated 60 million at-risk people in sub-Saharan Africa. This new grant to PATH, a global organization dedicated to accelerating health equity, expands on the early success of its Visualize No Malaria initiative and was announced at the World Malaria Day 2019 event hosted by the RBM Partnership to End Malaria in partnership with the City of Paris and the French government at the Hotel de Ville in Paris.

With the grant, PATH will support national governments and regional organizations in up to six sub-Saharan countries in the use of real-time data and analytics to bolster decision-making around elimination efforts. These data-informed insights allow officials to determine where and how to deploy resources to respond most effectively in fighting disease. The investment will also provide training to hundreds of frontline health workers and officials on how to use the power of timely and accurate data to tackle malaria and other diseases.

"Successful malaria elimination programs require accurate data that moves faster than the disease itself—to help shorten the distance and time it takes to find and treat cases, and even to predict risk and direct resources before cases occur," said Steve Davis, President and CEO of PATH. "We're excited to continue working with our technology partners to expand the support and tools governments need to get the upper hand in controlling and eventually eliminating a disease that still kills more than 400,000 people every year."

Originally launched in 2015 as a collaboration between PATH, Tableau Foundation, and the Zambian Ministry of Health, the Visualize No Malaria digital technologies make real-time, actionable data about malaria available to everyone from national and district-level health officials to thousands of frontline health workers.

Through the combination of improved use of data with other malaria control efforts, the Zambian government has reduced reported malaria cases by 85 percent and malaria-related deaths by 92 percent across a population of 1.8 million people in the country's Southern Province. Reducing the amount of time to see and understand health data from months to hours, health officials can now make faster decisions about the best ways to deploy a mix of interventions, including drug delivery, indoor residual spraying, bed net distribution, and other proven techniques to most effectively respond to existing cases and prevent new ones. In low-burden areas, this approach has proven to be a cost-effective way for governments to control malaria, and in high-burden areas, it could be an important differentiator in creating and sustaining steep drops in disease incidence.

The Visualize No Malaria tools and approach are currently being replicated in Senegal, which has seen a similar 60 percent drop in reported malaria cases across a northern Senegal population of 1.8 million in just two years, and the initiative is set to expand in Senegal and neighboring countries under this new commitment by partners.

"Senegal's National Malaria Control Program sees new tools to make data faster and easier to use and act upon as critical to helping us win the fight against malaria," said Dr. Doudou Séne, Director of Senegal's National Malaria Control Program. "With this new commitment, we can increase the number of districts where we use the Visualize No Malaria stack and make informed, real-time decisions across the nation, as well as support our cross-border collaboration with The Gambia."

In 2017, an estimated 219 million cases of malaria occurred globally, which resulted in an estimated 435,000 deaths, the vast majority in sub-Saharan Africa where the Visualize No Malaria effort is concentrated. Sixty-one percent of these deaths occurred in children under the age of five.

With this renewed commitment, PATH will work to mobilize an additional $2.5 million in funding through its country and agency partners—and together, the Visualize No Malaria initiative will:

  • Scale nationally across Zambia to serve the country's total population of 17 million people by equipping four remaining provinces.
  • Build on work and relationships in Senegal and The Gambia to expand the tools and training across West Africa.
  • Expand to three additional countries in the Elimination 8 initiative in southern Africa, allowing those countries to collaborate on an interoperable regional disease surveillance system.

For Tableau Foundation, this is the second major grant and first in the global health space following the $100 million pledge announced by Tableau CEO Adam Selipsky at the 2018 Tableau Conference. It also honors the commitment made in March 2018 at the Commonwealth Heads of Government meeting to expand the Visualize No Malaria initiative in sub-Saharan Africa.

"Data and analytics are only as valuable as the ability of a decision-maker to use them. Since the outset of the Visualize No Malaria initiative, we've seen countries and communities develop incredibly effective resources for fighting malaria and other complex health issues," said Neal Myrick, Global Head of Tableau Foundation. "We're proud to work alongside so many of our technology partners to help a generation of leaders make a meaningful difference in the lives of millions of men, women, and children."

As part of its Alteryx for Good program, Alteryx is contributing the data science and analytics engine as well as on-site training in Africa. This will allow spatial analytics, custom macros, data validation and cleansing, and repeatable workflows to accurately target and eliminate malaria across borders. The Alteryx Platform workflows designed for Visualize No Malaria run in 0.6 seconds, analyzing tens of millions of records and producing multiple outputs to address different analytical questions.

"The Alteryx for Good program was designed to empower nonprofit organizations in delivering game-changing social outcomes with data science and analytics," said Tori Adamo, Senior Manager, Alteryx for Good at Alteryx. "The Visualize No Malaria initiative is a prime example of our commitment to influencing social change with the Alteryx Platform and the impact technology can have in solving some of the world's biggest challenges. We are proud to support PATH and partner with fellow technology leaders to help eliminate malaria across the globe."

Exasol's in-memory analytics database compresses massive amounts of data and serves them up fast in low-resource, lower-bandwidth settings. "We strongly support Visualize No Malaria's approach of using data as the foundation for decision-making as part of their initiative to wipe out malaria," said Eva Murray, Head of Business Intelligence at Exasol. "We are proud to be part of this partnership and look forward to our continuous involvement in improving the lives of people in sub-Saharan Africa with our tools, expertise, and our passion for doing the right things."

Mapbox powers the mapping tools and geospatial data that can be combined with other datasets to create interactive maps within the Visualize No Malaria dashboards. Mapbox is providing remote and on-site technical support and training, as well as testing new offline mapping tools. "Our company's roots began with global development projects in Afghanistan, Congo, Haiti, and the United States, so the mission of Visualize No Malaria is very close to our hearts," said Mapbox CEO Eric Gundersen. "We built these tools to help people understand context in data so they can solve problems. It's incredible to see people use these platforms to literally save lives."

About Tableau Foundation
The Tableau Foundation is a philanthropic initiative led by the employees of Tableau Software (NYSE: DATA) that encourages the use of facts and analytical reasoning to solve the world's problems. Tableau Foundation grants combine Tableau's two most valuable resources—its people and its products—with financial support to nonprofits that are using data to reshape communities around the globe. To learn more, please visit www.tableaufoundation.org.

About Mapbox
Mapbox is the live location platform for more than 1.5 million developers. Mapbox's mapping, search, data, and navigation solutions power industry leaders, like Facebook, General Electric, Instacart, Porsche, Tableau, and The Weather Channel. Founded in 2010, Mapbox has offices in San Francisco; Washington, D.C.; Berlin; Helsinki; Minsk; and Shanghai. Learn more at www.mapbox.com.

About Exasol
Exasol is the future of data analytics. Its unique development team have combined cutting-edge innovation and unrivalled know-how to create the world's fastest data analytics platform, designed to give users the power, flexibility, and scalability to meet the demands of an organization's long-term data strategy. To learn more about Exasol, please visit www.exasol.com.

About Alteryx, Inc.
Revolutionizing business through data science and analytics, Alteryx offers an end-to-end analytics platform that empowers data analysts and scientists alike to break data barriers, deliver insights, and experience the thrill of getting to the answer faster. Organizations all over the world rely on Alteryx daily to deliver actionable insights. For more information, visit www.alteryx.com. 

About PATH
PATH is a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises, and investors to solve the world's most pressing health challenges. With expertise in science, health, economics, technology, advocacy, and dozens of other specialties, PATH develops and scales solutions—including vaccines, drugs, devices, diagnostics, and innovative approaches to strengthening health systems worldwide. For more information, visit http://www.path.org.

Related Links

https://endmalaria.org/news/paris-serve-host-city-world-malaria-day-2019

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.